文献速递静脉血栓栓塞慢性静脉疾病

采用自膨胀镍钛合金支架行下腔静脉腔内重建的结局

Outcomes of endovascular reconstruction of the inferior vena cava with self-expanding nitinol stents.
PubMed 文献 · J Vasc Surg Venous Lymphat Disord · 2018-03-15

基于前瞻性伯尔尼静脉支架登记研究,连续纳入62例下腔静脉腔内重建患者,技术成功61例(98%)。随访平均21个月,24个月一期、一期辅助和二期通畅率分别为57%、76%和87%,约三分之一患者需再干预以维持支架通畅。

要点

  • 技术成功61/62例(98%),平均使用4.5±1.9枚支架,84%采用髂静脉对吻支架。
  • 24个月一期、一期辅助、二期通畅率分别为57%(95%CI 50%-73%)、76%(95%CI 65%-86%)、87%(95%CI 80%-95%)。
  • 22例(36%)因症状性支架狭窄行腔内再干预,其中13例(21%)为完全支架闭塞。

核心结论

  • 镍钛合金支架行下腔静脉腔内重建的临床结局良好,但约三分之一患者需再干预以维持支架通畅,最可能原因是静脉流入道受损。

研究设计与样本

  • 前瞻性伯尔尼静脉支架登记研究,连续纳入62例下腔静脉腔内重建患者,平均年龄46±18岁。

主要发现

  • 33例(53%)因血栓后综合征、17例(27%)因急性血栓形成、12例(19%)因非血栓性下腔静脉闭塞接受治疗。
  • 技术成功61例(98%),平均使用4.5±1.9枚支架,84%采用髂静脉对吻支架。
  • 随访平均21个月,22例(36%)因症状性支架狭窄行腔内再干预,其中13例(21%)为完全支架闭塞。
  • 24个月一期、一期辅助、二期通畅率分别为57%(95%CI 50%-73%)、76%(95%CI 65%-86%)、87%(95%CI 80%-95%)。
  • 基线股静脉血栓后静脉造影改变或血栓形成史的患者较流入道静脉正常且无血栓史者更易丧失一期通畅(19例[48%] vs 3例[16%];P = .02)。

关键数值与推荐

  • 24个月一期通畅率57%(95%CI 50%-73%)。
  • 24个月一期辅助通畅率76%(95%CI 65%-86%)。
  • 24个月二期通畅率87%(95%CI 80%-95%)。
  • 基线股静脉血栓后改变或血栓史患者丧失一期通畅19例(48%)vs 无此改变者3例(16%),P = .02。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Occlusion of the inferior vena cava (IVC) often causes venous claudication, leg swelling, or skin changes. We hypothesized that the outcome of nitinol stents for endovascular reconstruction of the IVC is similar to the outcome reported for steel alloy stents. METHODS: From the prospective Bern Venous Stent Registry, we investigated technical success, patency rates, and clinical outcome in consecutive patients with endovascular IVC reconstruction. During routine follow-up visits, stent patency was assessed by duplex ultrasound. Clinical outcomes were evaluated using the Bozkaya score, Villalta score, and revised Venous Clinical Severity Score. RESULTS: Of the 62 patients (mean age, 46 ± 18 years), 33 (53%) patients were treated for the post-thrombotic syndrome, 17 (27%) for acute thrombosis, and 12 (19%) for nonthrombotic IVC occlusion. Technical success was achieved in 61 (98%) patients, with a mean of 4.5 ± 1.9 stents (iliac kissing stents in 84%). During follow-up (mean, 21 months), 22 (36%) underwent endovascular reintervention for symptomatic stent stenosis (13 [21%] with complete stent occlusion). Primary, primary assisted, and secondary patency rates at 24 months were 57% (95% confidence interval [CI], 50%-73%), 76% (95% CI, 65%-86%), and 87% (95% CI, 80%-95%), respectively. None developed new ulcers, and all eight patients with venous ulcers at baseline had complete healing. Twenty-nine (48%) patients showed significant clinical improvement, and another 26 (43%) were free from any symptoms or signs of venous hypertension. Patients with post-thrombotic venographic changes of the femoral veins at baseline or a history of thrombosis were more likely to lose primary patency compared with patients with normal leg inflow veins and no history of thrombosis (19 [48%] vs 3 [16%]; P = .02). CONCLUSIONS: The clinical outcome of endovascular reconstruction of the IVC with nitinol stents was favorable. However, approximately one-third of the patients required reintervention to maintain stent patency, most likely because of the impaired venous inflow.

来源:J Vasc Surg Venous Lymphat Disord,查看原文。版权归原作者所有。

引用

  1. Sebastian T, Dopheide JF, Engelberger RP, et al. Outcomes of endovascular reconstruction of the inferior vena cava with self-expanding nitinol stents. J Vasc Surg Venous Lymphat Disord. 2018. PMID: 29550177. doi:10.1016/j.jvsv.2017.11.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。